
Russak Personalized Medicine: Two Practices, One Bigger Question
Introduction: Why “Russak Personalized Medicine” Leads to Two Different Doctors
People who search for “Russak personalized medicine” often get confusing results. The phrase can point to two unrelated medical practices, run by two different physicians, in two different parts of the country.
One is a concierge internal medicine group in Colorado led by Dr. Floyd Russak. The other is a longevity-focused dermatology clinic in New York City founded by Dr. Julie Russak. Both use the word “personalized,” but they mean very different things. For one practice, personalization is about access: more time, more availability, and a closer relationship with a physician. For the other, it is about biology: diagnostic testing that shows what is happening inside a patient’s body.
Both models raise a question that most searchers never think to ask. When biomarker testing identifies a patient’s specific skin needs, how does that finding become a treatment made for that patient? Neither a concierge membership nor a diagnostic panel answers this on its own. PCAB-accredited compounding pharmacies such as Nationwide Compounding Rx® fill that role.
This article explains both Russak practices, the two meanings of “personalized” medicine, and the gap between diagnosis and treatment.
Two Providers, One Search Term: Untangling the Confusion
Search engines tend to group the two practices together for two reasons: the shared surname and the shared marketing language. Both practices describe their care as individualized, customized, or personalized, so algorithms treat them as closely related.
This mixes two kinds of search intent. Some people want to find a specific practice, perhaps to book an appointment or check membership pricing. Others want to understand what “personalized medicine” means, especially for skin and aging. Separating the two practices first makes the rest of the discussion easier to follow.
Dr. Floyd Russak’s Russak Personalized Medicine (Greenwood Village, Colorado)
The practice that uses the exact name “Russak Personalized Medicine” was founded in 1999 by Floyd B. Russak, M.D., a Harvard-trained internist who previously owned East-West Health Centers. It also operates as RPM Family Health and has a team of roughly 13 physicians and clinicians, including Dr. Beatriz Linn, Heather Whiting, PA-C, and Dr. Jordan Walker.
The practice serves Greenwood Village, Highlands Ranch, Centennial, Littleton, and the greater Denver area. It offers concierge and urgent-care internal medicine to patients of all ages, from children to older adults.
Business Management Review Magazine named the practice to its “Top 10 Concierge Services Providers – 2024” list. In the accompanying interview, Dr. Russak described the practice’s focus on C-suite executives and on integrated, individualized wellness plans.
Dr. Julie Russak’s Longevity Dermatology Clinic (NYC)
Julie Russak, MD, FAAD, is a board-certified dermatologist. She founded Russak Dermatology Clinic and Russak+ Aesthetic Center in Midtown Manhattan. She is also an Associate Clinical Professor at the Icahn School of Medicine at Mount Sinai and is known as a leading voice in longevity dermatology and regenerative aesthetic medicine.
Her approach relies on diagnostic testing. Bloodwork, DNA methylation analysis, hair mineral testing, gut health assessments, and food-sensitivity panels are used to build individualized skin and anti-aging plans. According to industry coverage, the clinic launched its Anti-Aging Wellness program roughly five years ago, and it remains a flagship offering.
Two Different Meanings of “Personalized” Medicine
The key difference between the two practices is personalized access versus personalized biology.
This matters because patients who look for one kind of personalization often need the other as well. Neither model finishes the job alone. Concierge access alone does not produce a treatment based on a patient’s biology. Biomarker testing alone does not ensure that a treatment reflects what the tests found.
Personalized Access: The Concierge Medicine Model
At Russak Personalized Medicine in Colorado, membership pricing is straightforward:
- Dr. Russak’s Personalized Medicine Program: $2,800 per year (or $750 per quarter) for individuals; $5,400 per year (or $1,400 per quarter) for families
- Other in-practice providers: Lower tiers are available, such as Dr. Walker at $1,800 per year for individuals
Membership benefits include:
- A free 2.5-hour executive physical
- 24/7 phone and text access to the physician
- Discounts on supplements, acupuncture, nutritional counseling, and biofeedback
- Free or reduced-rate cardiopulmonary screenings
- Access to the Galleri GRAIL multi-cancer early detection test
The practice also has particular depth in hormone therapy, lipid management, and preventive cardiology.
This model is part of a fast-growing market. The concierge medicine industry is projected to grow from roughly $20 to $25 billion in 2026 to $41 to $49 billion by the early 2030s. Demand comes from patients who want unhurried, prevention-focused care.
In this model, “personalized” refers to convenience, time, and the doctor-patient relationship. It describes how care is delivered, not how treatment is tailored to a patient’s biology.
Personalized Biology: The Diagnostic-Driven Dermatology Model
Dr. Julie Russak’s Regenerative Aesthetics/Anti-Aging Wellness program costs $3,700 and includes:
- Hair mineral testing
- Food intolerance testing
- DNA methylation testing
- Gut health testing
- General bloodwork
- Six health-coaching sessions over 6 to 12 months
Patients typically repeat the program every two years.
This model looks for the biological markers behind a person’s skin aging, inflammation, or sensitivity. It asks why a patient’s skin behaves the way it does, rather than when the patient can see the doctor.
The approach reflects a wider change in dermatology. The field is moving away from treating conditions with the same protocol for everyone and toward precision care guided by biomarkers.
The Bigger Question: What Does “Personalized Medicine” Actually Mean in Dermatology?
Comparing the two practices leads to a larger point: true personalization connects diagnosis to treatment. Offering only one of the two is not enough.
The science is moving quickly. A 2024 peer-reviewed review in Current Issues in Molecular Biology found that biomarker-driven precision medicine has already succeeded in skin malignancies. The review also found that the field is moving toward AI-powered, multi-omics personalized care for conditions such as:
- Psoriasis
- Atopic dermatitis
- Hidradenitis suppurativa
- Alopecia areata
- Vitiligo
- Chronic spontaneous urticaria
Dermatology Times has reported that research in genetic profiling is making personalized medicine a practical reality in general dermatology. One example is the identification of gene polymorphisms that affect how patients respond to psoriasis biologics. This kind of information could help clinicians choose the therapy class most likely to work for a given patient.
The pharmaceutical industry is heading the same way. In 2025, personalized medicines made up approximately 36% of all new FDA drug approvals, the sixth consecutive year at that level. Individualized therapeutics are now mainstream, and the trend reaches into topical dermatology.
The Missing Link: From Diagnosis to Treatment
Suppose a patient completes DNA methylation testing, a food-sensitivity panel, or genetic profiling. The results show specific inflammation patterns, sensitivities, or tolerances for certain ingredients. What happens next?
In many cases, the patient is sent to a commercial pharmacy. The shelves there hold standardized, mass-produced formulations. These products cannot reflect an individual’s biomarker profile, allergies, or sensitivities, no matter how detailed the diagnostic workup was.
Why a Commercial Pharmacy Shelf Can’t Deliver True Individualization
Retail dermatology products are made for the average patient. They usually come with:
- Fixed strengths, whether or not that strength suits the patient
- Fixed ingredient combinations, which may include actives the patient does not need or tolerate poorly
- Dyes, fillers, and preservatives, which may trigger a sensitivity that testing has already identified
Biomarker testing, by contrast, shows needs that are specific to the individual: particular inflammation pathways, particular allergen sensitivities, and particular tolerances for active ingredients.
This mismatch is the unsolved problem behind both Russak models. Access exists, and diagnostics exist. What is often missing is the ability to deliver a formulation built for one patient.
How PCAB-Accredited Compounding Closes the Gap
Compounding pharmacies turn “personalized medicine” into an actual product. A compounding pharmacist does not hand over a standard product. Instead, the pharmacist prepares a formulation to the prescriber’s specifications: the right strength, the right combination of actives, and none of the ingredients the patient needs to avoid.
Dermatology is central to this work. It accounts for roughly 35% of the compounded topical drug market, making it the largest end-use segment.
The market is growing as well. The U.S. compounding pharmacy market is valued at approximately $7.42 billion in 2026 and is projected to reach $12.79 billion by 2035, a compound annual growth rate of 6.24%. That growth reflects rising demand for individualized treatment.
Nationwide Compounding Rx: Turning Diagnostic Data Into Custom Formulations
Nationwide Compounding Rx® is a Scottsdale, Arizona-based compounding pharmacy. It is PCAB accredited and USP 800 compliant, and its team has more than 40 years of combined experience.
Its custom dermatology compounding services include topical formulations for:
- Acne and rosacea
- Eczema, psoriasis, and atopic dermatitis
- Scarring and stretch marks
- Dark spots
- Signs of aging
Each formulation can be tailored to an individual’s required strength, ingredients, and allergen restrictions. Preparations can be made free of dyes, fillers, preservatives, and allergens. This directly addresses sensitivities that diagnostic testing may reveal, such as a food-sensitivity panel flagging a reaction or bloodwork pointing to an inflammatory pattern.
Practical advantages include:
- 1 to 2 business day turnaround, with same-day pickup available for some medications
- Nationwide shipping, with availability depending on medication type, state regulations, and prescription requirements
- Independent third-party testing to verify quality and consistency
- High-grade chemicals sourced from FDA-inspected and cleared vendors
- Both sterile and non-sterile compounding capabilities
The pharmacy works with prescribers through a four-step framework: Connect, Collaborate, Create, Care. A physician shares diagnostic findings and treatment goals. The pharmacy team works with the physician to design a suitable formulation. The preparation is compounded to specification. Ongoing support continues through refills and adjustments.
The same approach applies outside dermatology. Nationwide Compounding Rx also provides:
- Bioidentical hormone replacement therapy (BHRT), with formulas that can be adjusted at each refill based on lab results
- Pain management topicals that localize treatment and reduce systemic side effects
- GLP-1 and peptide support
- Pediatric formulations in kid-friendly forms and flavors
- Sports medicine preparations for recovery and inflammation
Choosing the Right Kind of “Personalized” Care for Your Needs
Patients deciding between these models can start with what they need most:
- For convenience, extended access, and preventive screening, a concierge model like Dr. Floyd Russak’s practice in Colorado may be the right fit.
- For biomarker-driven skin diagnostics, a longevity dermatology program like Dr. Julie Russak’s in New York may be more relevant.
In either case, patients should ask what happens after the diagnosis. Can the treatment be formulated to match their test results, or will it default to standard commercial products?
Useful questions for a patient to ask a physician or dermatologist include:
- Can this topical treatment be compounded at a strength specific to the patient’s needs?
- Can a formulation be made without the dyes, fillers, or preservatives the patient may be sensitive to?
- Can active ingredients be combined into a single preparation to simplify the patient’s routine?
- Does the practice work with a PCAB-accredited compounding pharmacy?
- How will the formulation be adjusted if follow-up testing changes?
Conclusion: Personalization Isn’t Complete Until Diagnosis Becomes Treatment
The search term “Russak personalized medicine” leads to two respected but very different practices. Dr. Floyd Russak’s Colorado group represents personalized access: concierge membership, 24/7 availability, and preventive screening. Dr. Julie Russak’s New York clinic represents personalized biology: diagnostic panels that show what drives each patient’s skin health.
Both models leave out a third step. True personalized medicine requires turning diagnostic insight into a formulation compounded for the individual patient. Without that step, even the most detailed biomarker profile may end with a product designed for the average patient.
PCAB-accredited compounding pharmacies like Nationwide Compounding Rx® connect diagnosis to treatment, which neither concierge access nor diagnostic testing can do alone.
Talk to Nationwide Compounding Rx About Custom Dermatology Formulations
Patients and healthcare providers who want custom dermatology compounding based on diagnostic or biomarker results can contact the Nationwide Compounding Rx® team.
There are two ways to start a prescription or formulation request:
- Provider Portal: Submit and manage prescriptions, track orders, and communicate directly with the pharmacy team.
- Patient Portal: Access account information and manage refill and support requests.
Contact Nationwide Compounding Rx®:
- Phone: (480) 499-8379
- Website: nationwidecompounding.com
- Address: 14000 N. Hayden Rd., Suite 104, Scottsdale, AZ 85260
- Hours: Monday to Friday, 7:00 AM to 3:30 PM
Whether a patient came through a concierge practice, a longevity dermatology program, or their own research, a compounded formulation built for them can complete their personalized care.
Related Posts
Nearly half of all patients don't adhere to their prescribed therapies, and standard dosing often falls short too. Learn how compounding pharmacy helps prescribers close both the dosing and adherence gaps through personalized formulations, improved delivery methods, and practice-level benefits like fewer call-backs and stronger patient retention.
Curious what USP 800 compliance in pharmacy actually means? This guide breaks down the safety standard governing hazardous drug handling, why it matters for patients and pharmacy staff, and how to verify a compounding pharmacy meets 2026 requirements.
Costco Specialty Pharmacy operates as a phone-only, PBM-dependent service, separate from Costco's retail and mail-order pharmacies. This guide breaks down how it works in 2026, where it falls short for patients with complex needs, and what alternatives exist.
Headlines claiming BPC-157 is 'now legal' for compounding pharmacies oversimplify a complex 2023-2026 regulatory timeline. This article breaks down the FDA's Category 2 removal, the July 2026 PCAC vote, and what the ongoing rulemaking process actually means for patients, prescribers, and athletes.



